Veterinary Animal Healthcare Market Summary
According to Market Research Future analysis, the Veterinary Animal Healthcare Market size was valued at USD 38.81 Billion in 2024 and the market is projected to grow from USD 40.18 Billion in 2025 to USD 56.9 Billion by 2035, exhibiting a CAGR of 3.54% during the forecast period 2025–2035. North America led the market with over 38.65% share, generating around USD 15 billion in revenue.
Rising pet ownership and increasing awareness of animal health are key growth drivers for the Veterinary Animal Healthcare Market. Expanding demand for advanced treatments, vaccinations, and preventive care services is significantly boosting veterinary healthcare adoption across both companion and livestock animals globally.
According to the World Health Organization, zoonotic diseases account for over 60% of emerging infectious diseases, while the Centers for Disease Control and Prevention estimates 1 in 5 people experience zoonotic illnesses annually, highlighting growing need for strong veterinary healthcare systems and preventive animal health management globally.
Key Market Trends & Highlights
The Veterinary Animal Healthcare Market is experiencing robust growth driven by technological advancements and increasing pet ownership.
- North America leads with 38.65% share in 2024, supported by advanced veterinary infrastructure and high pet care spending.
- Europe holds 25.77% share, valued at USD 10 billion in 2024, driven by strong animal healthcare systems.
- Companion animals dominate with 62% share, driven by rising global pet ownership and increased healthcare spending trends.
- Pharmaceuticals lead with 58% share, while biologics grow rapidly due to increasing vaccination and preventive care adoption.
Market Size & Forecast
| 2024 Market Size | 38.81 (USD Billion) |
| 2035 Market Size | 56.9 (USD Billion) |
| CAGR (2025 - 2035) | 3.54% |
Major Players
Companies such as Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Virbac (FR), Ceva Santé Animale (FR), Merial (US), Vetoquinol (FR), Dechra Pharmaceuticals (GB) are some of the major participants in the global market.